New Treatment Options in Uveitis

New Treatment Options in Uveitis

Noninfectious uveitis continues to be a leading cause of preventable blind…

Expiration Date: 5/30/2021

Max Credits: 1.25

View Activity

New Treatment Options in Uveitis

New Treatment Options in Uveitis

Noninfectious uveitis continues to be a leading cause of preventable blind…

Expiration Date: 5/30/2021

Max Credits: 0

View Activity

Impact of Treatment Protocol on Long-Term Outcomes – Frequency of Injections, Fixed Interval Dosing, Treat and Extend, PRN

Impact of Treatment Protocol on Long-Term Outcomes – Frequency of Injections, Fixed Interval Dosing, Treat and Extend, PRN

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0.25

View Activity

Optimization of Treatment Dosing to Achieve Regression of Diabetic Retinopathy

Optimization of Treatment Dosing to Achieve Regression of Diabetic Retinopathy

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0.25

View Activity

Transitioning Treatment From Diabetic Macular Edema to Diabetic Retinopathy

Transitioning Treatment From Diabetic Macular Edema to Diabetic Retinopathy

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0.25

View Activity

Extending the Anti-VEGF Treatment Interval and Its Effect on Visual Outcomes

Extending the Anti-VEGF Treatment Interval and Its Effect on Visual Outcomes

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0.25

View Activity

Assessing Retinal Fluid – Does Early Anatomic Dryness Make a Difference in Outcomes?

Assessing Retinal Fluid – Does Early Anatomic Dryness Make a Difference in Outcomes?

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0.25

View Activity

Treatment of Proliferative Versus Non-Proliferative DR

Treatment of Proliferative Versus Non-Proliferative DR

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0.25

View Activity

Current Undertreatment of Patients With nAMD – Defining the Need for More Flexible Dosing

Current Undertreatment of Patients With nAMD – Defining the Need for More Flexible Dosing

Pinnacle clinical trials evaluating anti–vascular endothelial growth facto…

Expiration Date: 7/22/2021

Max Credits: 0.25

View Activity

Using Current Anti-VEGF Agents to Lessen the Injection Burden and Improve Adherence and Visual Outcomes

Using Current Anti-VEGF Agents to Lessen the Injection Burden and Improve Adherence and Visual Outcomes

Pinnacle clinical trials evaluating anti–vascular endothelial growth facto…

Expiration Date: 7/22/2021

Max Credits: 0.25

View Activity